Product Manager Scott Myers To Present At 2nd Global Summit On Artificial Intelligence

By Author: Orson Amiri
Total Articles: 418
Comment this article

Oncotelic Therapeutics, Inc. (OTCQB) announced that Scott Myers, Product Manager, will present at the 2nd Global Summit on Artificial Intelligence. Hosted digitally, the summit focuses on advancing global development through AI. Myers, representing Oncotelic's 45% joint venture with Dragon Capital Limited, will showcase the PubMed Corpus Builder, a tool developed by Sapu Bioscience LLC. This AI-driven tool is designed to autonomously gather and analyze large volumes of medical papers from the PubMed Central Database, significantly speeding up cancer research by filtering documents and interpreting graphs and charts.

Oncotelic, formerly known as Mateon Therapeutics, focuses on oncology drug development and AI-driven solutions to enhance cancer treatment outcomes. Their portfolio includes rare pediatric cancer treatments and the acquisition of PointR Data Inc. and AL-101 for various conditions. For more information on the summit, visit here.

Read More - https://www.techdogs.com/tech-news/globe-newswire/product-manager-scott-myers-to-present-at-2nd-global-summit-on-artificial-intelligence